Vaccine Development

Clinical Trials mRNA Technology mRNA Vaccines COVID-19 Vaccines Regulatory Approval Safety and Efficacy Advisory Committees Emergency Use Authorization Vaccine Research Research Funding Vaccine Safety COVID-19 Pharmaceutical Companies Regulatory Agencies Covid-19 Vaccines RNA Technology Vaccine Supply Immunization Programs Biotechnology Vaccine Production Manufacturing Capacity Chikungunya Virus FDA Regulations Immunology Vaccine Effectiveness Immunization Regulatory Bodies Vaccine Hubs

AI Pinpoints Single-Protein Mpox Target That Elicits Neutralizing Antibodies in Mice

AlphaFold 3 guidance focuses countermeasure design on OPG153 to enable simpler manufacturing than whole‑virus shots.

Florida Starts Process to Drop Four School Vaccine Requirements

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine